Filtered By:
Therapy: Hormonal Therapy
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 49 results found since Jan 2013.
Concerns About Compounded Bioidentical Menopausal Hormone Therapy
Cancer J. 2022 May-Jun 01;28(3):241-245. doi: 10.1097/PPO.0000000000000597.ABSTRACTFollowing the release of the Women's Health Initiative data, women began to use compounded bioidentical hormone therapy (cBHT) in the misguided belief of greater safety and efficacy than traditional hormone therapy. New guidelines recommend government-approved hormone therapy for symptomatic healthy menopausal women younger than 60 years or within 10 years of menopause at the time of initiation. For women requesting bioidentical hormones, those similar to the hormones present before menopause, there are many government-approved hormone thera...
Source: Cancer Journal - May 20, 2022 Category: Cancer & Oncology Authors: JoAnn V Pinkerton Source Type: research
Hormone therapy use in the Canadian Longitudinal Study on Aging: a cross-sectional analysis
Conclusions:These findings provide a recent national picture of HT use in Canada that may be used to inform opportunities for improved physician–patient communication regarding menopause management.
Objective:
The aim of the study was to assess the prevalence and factors associated with hormone therapy (HT) use among Canadian women.
Methods:
Baseline data from the Tracking cohort of the Canadian Longitudinal Study on Aging (CLSA) was used for this analysis. The main outcome was HT use among women aged 45-85 years, defined as current, past, and never users. Multinomial logistic regression models were used to examin...
Source: Menopause - January 1, 2018 Category: OBGYN Tags: Original Articles Source Type: research
